208 related articles for article (PubMed ID: 23278865)
1. Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin.
Dudley A; Thomason J; Fritz S; Grady J; Stokes J; Wills R; Pinchuk L; Mackin A; Lunsford K
J Vet Intern Med; 2013; 27(1):141-9. PubMed ID: 23278865
[TBL] [Abstract][Full Text] [Related]
2. Platelet cyclooxygenase expression in normal dogs.
Thomason J; Lunsford K; Mullins K; Stokes J; Pinchuk L; Wills R; McLaughlin R; Langston C; Pruett S; Mackin A
J Vet Intern Med; 2011; 25(5):1106-12. PubMed ID: 21985141
[TBL] [Abstract][Full Text] [Related]
3. The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs.
Thomason J; Lunsford K; Stokes J; Pinchuk L; Wills R; Langston C; Pruett S; Mackin A
J Vet Intern Med; 2012; 26(6):1389-401. PubMed ID: 23106529
[TBL] [Abstract][Full Text] [Related]
4. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
Guthikonda S; Lev EI; Patel R; DeLao T; Bergeron AL; Dong JF; Kleiman NS
J Thromb Haemost; 2007 Mar; 5(3):490-6. PubMed ID: 17319904
[TBL] [Abstract][Full Text] [Related]
5. Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C.
Yi X; Zhou Q; Lin J; Chi L; Han Z
J Atheroscler Thromb; 2013; 20(1):65-72. PubMed ID: 22972377
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
7. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
[TBL] [Abstract][Full Text] [Related]
8. Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs.
McLewee N; Archer T; Wills R; Mackin A; Thomason J
J Vet Pharmacol Ther; 2018 Feb; 41(1):60-67. PubMed ID: 28664658
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs.
Thomason J; Archer T; Wills R; Press S; Mackin A
J Vet Intern Med; 2016 Jul; 30(4):1022-30. PubMed ID: 27156005
[TBL] [Abstract][Full Text] [Related]
10. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
11. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
12. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
Dragani A; Pascale S; Recchiuti A; Mattoscio D; Lattanzio S; Petrucci G; Mucci L; Ferrante E; Habib A; Ranelletti FO; Ciabattoni G; Davì G; Patrono C; Rocca B
Blood; 2010 Feb; 115(5):1054-61. PubMed ID: 19887674
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action.
Patrignani P; Tacconelli S; Piazuelo E; Di Francesco L; Dovizio M; Sostres C; Marcantoni E; Guillem-Llobat P; Del Boccio P; Zucchelli M; Patrono C; Lanas A
J Thromb Haemost; 2014 Aug; 12(8):1320-30. PubMed ID: 24942808
[TBL] [Abstract][Full Text] [Related]
17. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
19. Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.
Takahashi S; Ushida M; Komine R; Shimodaira A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
Thromb Res; 2008; 121(4):509-17. PubMed ID: 17631383
[TBL] [Abstract][Full Text] [Related]
20. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.
Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM
Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
